Exclusive – RX Border Defense’s Patsy Writesman on CCP’s Stranglehold on Skinny: FDA’s ‘Green List’ Surrendered GLP-1 Supply Chain to China

March 30, 2026
10:45 pm

▶

Listen to Article

In a bombshell revelation that's got the health freedom crowd buzzing, RX Border Defense's Patsy Writesman just dropped a truth bomb on Breitbart News: the FDA's so-called Green List has handed the keys to America's GLP-1 obesity drug supply chain straight to the Chinese Communist Party (CCP). These are the hot-ticket meds like Ozempic and Wegovy, fueling a $100 billion market as Americans battle the bulge. Writesman, speaking at an event on China's creeping threats, slammed the FDA for greenlighting Chinese manufacturers without rigorous vetting, effectively surrendering our skinny drugs to Beijing's stranglehold. It's not just about weight loss—it's a national security gut punch, with the U.S. now 90% reliant on China for active pharmaceutical ingredients (APIs), per recent congressional reports. One supply hiccup from Xi's regime, and shelves go bare, just like we saw with fentanyl precursors. Dig deeper, and this FDA fumble reeks of the same regulatory capture that's eroding American sovereignty across sectors. Remember the baby formula crisis of 2022? China filled the void then too, proving they're always ready to exploit our vulnerabilities. Writesman's warning isn't hyperbole—GLP-1s aren't just vanity pills; they're tied to metabolic health, diabetes prevention, and even cognitive benefits, affecting millions. With China dominating 70-80% of global API production (FDA data), we're one tariff war or Taiwan flare-up from rationing. This isn't isolated; it's part of Beijing's playbook to weaponize dependencies, from rare earths to semiconductors. For the 2A community, this hits home harder than a mag dump at the range. Just as gun owners fight backdoor gun grabs via ATF regulatory sleight-of-hand, patriots must rally against FDA overreach that's outsourcing our health to a hostile regime plotting our downfall. If the feds can kneecap domestic drug production with a Green List wink to the CCP, imagine what they'd do to ammo or firearms manufacturing under public health pretexts. Time to demand onshoring, FDA accountability, and policies that prioritize American innovation over globalist surrender—because self-reliance isn't just for your AR-15; it's for surviving skinny-drug shortages too. Stay vigilant, stock up, and keep fighting the real war on independence.

Best FFL Software Ranked and Compared!

In a bombshell revelation that’s got the health freedom crowd buzzing, RX Border Defense’s Patsy Writesman just dropped a truth bomb on Breitbart News: the FDA’s so-called Green List has handed the keys to America’s GLP-1 obesity drug supply chain straight to the Chinese Communist Party (CCP). These are the hot-ticket meds like Ozempic and Wegovy, fueling a $100 billion market as Americans battle the bulge. Writesman, speaking at an event on China’s creeping threats, slammed the FDA for greenlighting Chinese manufacturers without rigorous vetting, effectively surrendering our skinny drugs to Beijing’s stranglehold. It’s not just about weight loss—it’s a national security gut punch, with the U.S. now 90% reliant on China for active pharmaceutical ingredients (APIs), per recent congressional reports. One supply hiccup from Xi’s regime, and shelves go bare, just like we saw with fentanyl precursors.

Dig deeper, and this FDA fumble reeks of the same regulatory capture that’s eroding American sovereignty across sectors. Remember the baby formula crisis of 2022? China filled the void then too, proving they’re always ready to exploit our vulnerabilities. Writesman’s warning isn’t hyperbole—GLP-1s aren’t just vanity pills; they’re tied to metabolic health, diabetes prevention, and even cognitive benefits, affecting millions. With China dominating 70-80% of global API production (FDA data), we’re one tariff war or Taiwan flare-up from rationing. This isn’t isolated; it’s part of Beijing’s playbook to weaponize dependencies, from rare earths to semiconductors.

For the 2A community, this hits home harder than a mag dump at the range. Just as gun owners fight backdoor gun grabs via ATF regulatory sleight-of-hand, patriots must rally against FDA overreach that’s outsourcing our health to a hostile regime plotting our downfall. If the feds can kneecap domestic drug production with a Green List wink to the CCP, imagine what they’d do to ammo or firearms manufacturing under public health pretexts. Time to demand onshoring, FDA accountability, and policies that prioritize American innovation over globalist surrender—because self-reliance isn’t just for your AR-15; it’s for surviving skinny-drug shortages too. Stay vigilant, stock up, and keep fighting the real war on independence.

Share this story